Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06451302
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-06-02
Brief Title:
Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma a Prospective Multicenter Cohort Study
Sponsor:
Yizhuo Zhang
Organization:
Sun Yat-sen University
Study Overview
Official Title:
A Prospective Multicenter Cohort Study of Outcome and Safety Profile of Risk Stratification Oriented Treatment in Pediatric Ewing Sarcoma in China
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim is to evaluate the outcome and safety of risk-stratification oriented treatment for pediatric Ewing sarcoma in multicenters
Detailed Description:
Pediatric Ewing sarcoma is stratified into three risk groupslow risk moderate risk and high risk accordiong to age longest diameter of lesion volume and tumor site Participants receive chemotherapy with corresponding intensity The prospective study is to assess efficacy outcome and safety profile of different treatment received for pediatric Ewing sarcoma
The prospecitive single-arm study is to be conducted in Chinese multicenters
The prospecitive single-arm study is to be conducted in Chinese multicenters
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None